热门资讯> 正文
Trxade Health以价值1.03亿美元的全股票交易收购Sciencia
2024-07-26 22:47
- TRxADE HEALTH (NASDAQ:MEDS) and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction.
- TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock.
- TRxADE will change its name to “Scienture Holdings” after the future conversion of the non-voting convertible preferred stock, and the combined company is intended to continue as a Nasdaq-listed Co.
- The Business Combination results in a combined Co. that will be focused on bringing to market innovative branded, specialty pharmaceutical products that significantly enhance the standard of care, while adding value to patients, caregivers and the healthcare system.
More on Trxade Group
- Financial information for Trxade Group
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
